146 related articles for article (PubMed ID: 37454866)
1. Augmented oxidative stress, accumulation of DNA damage and impaired DNA repair mechanisms in thrombotic primary antiphospholipid syndrome.
Pappa M; Ntouros PA; Papanikolaou C; Sfikakis PP; Souliotis VL; Tektonidou MG
Clin Immunol; 2023 Sep; 254():109693. PubMed ID: 37454866
[TBL] [Abstract][Full Text] [Related]
2. Geriatric Frailty Is Associated With Oxidative Stress, Accumulation, and Defective Repair of DNA Double-Strand Breaks Independently of Age and Comorbidities.
Kravvariti E; Ntouros PA; Vlachogiannis NI; Pappa M; Souliotis VL; Sfikakis PP
J Gerontol A Biol Sci Med Sci; 2023 Mar; 78(4):603-610. PubMed ID: 36209410
[TBL] [Abstract][Full Text] [Related]
3. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
[TBL] [Abstract][Full Text] [Related]
4. Oxidative Stress and Deregulated DNA Damage Response Network in Lung Cancer Patients.
Stefanou DT; Kouvela M; Stellas D; Voutetakis K; Papadodima O; Syrigos K; Souliotis VL
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740268
[TBL] [Abstract][Full Text] [Related]
5. Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome.
Verrou KM; Sfikakis PP; Tektonidou MG
J Autoimmun; 2023 Jan; 134():102978. PubMed ID: 36587511
[TBL] [Abstract][Full Text] [Related]
6. Chronological Age and DNA Damage Accumulation in Blood Mononuclear Cells: A Linear Association in Healthy Humans after 50 Years of Age.
Vlachogiannis NI; Ntouros PA; Pappa M; Kravvariti E; Kostaki EG; Fragoulis GE; Papanikolaou C; Mavroeidi D; Bournia VK; Panopoulos S; Laskari K; Arida A; Gorgoulis VG; Tektonidou MG; Paraskevis D; Sfikakis PP; Souliotis VL
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108309
[TBL] [Abstract][Full Text] [Related]
7. Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis.
Vlachogiannis NI; Pappa M; Ntouros PA; Nezos A; Mavragani CP; Souliotis VL; Sfikakis PP
Front Immunol; 2020; 11():582401. PubMed ID: 33123169
[TBL] [Abstract][Full Text] [Related]
8. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
Front Immunol; 2019; 10():764. PubMed ID: 31040845
[TBL] [Abstract][Full Text] [Related]
9. DNA damage accumulation, defective chromatin organization and deficient DNA repair capacity in patients with rheumatoid arthritis.
Souliotis VL; Vlachogiannis NI; Pappa M; Argyriou A; Sfikakis PP
Clin Immunol; 2019 Jun; 203():28-36. PubMed ID: 30930144
[TBL] [Abstract][Full Text] [Related]
10. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
[TBL] [Abstract][Full Text] [Related]
11. Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients.
Li C; Zuo Y; Zhang S; Makris UE; Karp DR; Li Z
Chin Med J (Engl); 2022 Mar; 135(6):658-664. PubMed ID: 35143425
[TBL] [Abstract][Full Text] [Related]
12. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
13. Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome.
Rosa Dos Santos AP; de Oliveira Vaz C; Hounkpe BW; Jacintho BC; Oliveira JD; Tripiquia Vechiatto Mesquita GL; Pereira Dos Santos I; Annichino-Bizzacchi J; Appenzeller S; de Moraes Mazetto Fonseca B; Orsi FA
Lupus; 2022 Aug; 31(9):1067-1077. PubMed ID: 35612283
[No Abstract] [Full Text] [Related]
14. Impact of plasma homocysteine and prothrombin G20210 A on primary antiphospholipid syndrome.
Ames PR; Margaglione M; Tommasino C; Bossone A; Iannaccone L; Brancaccio V
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):699-704. PubMed ID: 11734671
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
[TBL] [Abstract][Full Text] [Related]
16. Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study.
Su Z; Huang Z; Zhao J; Li M; Hu J; Zeng X; Hu C; Yang B
Clin Appl Thromb Hemost; 2022; 28():10760296221081129. PubMed ID: 35379020
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies.
Forastiero RR; Martinuzzo ME; de Larrañaga GF
Lupus; 2005; 14(2):129-36. PubMed ID: 15751817
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
[TBL] [Abstract][Full Text] [Related]
19. 8-isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study.
Sciascia S; Roccatello D; Bertero MT; Di Simone D; Cosseddu D; Vaccarino A; Bazzan M; Rossi D; Garcia-Fernandez C; Ceberio L; Stella S; Menegatti E; Baldovino S
Inflamm Res; 2012 Aug; 61(8):809-16. PubMed ID: 22638905
[TBL] [Abstract][Full Text] [Related]
20. Oxidative DNA damage is concurrently repaired by base excision repair (BER) and apyrimidinic endonuclease 1 (APE1)-initiated nonhomologous end joining (NHEJ) in cortical neurons.
Yang JL; Chen WY; Mukda S; Yang YR; Sun SF; Chen SD
Neuropathol Appl Neurobiol; 2020 Jun; 46(4):375-390. PubMed ID: 31628877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
